Aerpio Pharmaceuticals, Inc. carries a market capitalization of 53.67M, placing it among publicly traded companies globally.
| Market Cap | 53.67M |
| Enterprise Value | N/A |
Aerpio Pharmaceuticals, Inc.'s stock has declined approximately -88.3351% over the past 52 weeks. The 50-day moving average sits at 31.53, while the 200-day moving average is 25.92.
| Beta (5Y) | N/A |
| 52-Week Price Change | -88.3351% |
| 50-Day Moving Average | 31.53 |
| 200-Day Moving Average | 25.92 |
| Average Volume (20 Days) | N/A |
Aerpio Pharmaceuticals, Inc.'s most recent stock split took place on August 27, 2021 with a 15:1 split ratio.
| Last Split Date | 8/27/2021 |
| Split Ratio | 15:1 |